Mydriasis Market Insight, Epidemiology, and Market Forecast 2024-2032
Pharmaceuticals
$4750|GR - 145777|Published date: 12 December, 2024
Mycosis Fungoides Market Insight, Epidemiology, and Market Forecast 2024-2032
Pharmaceuticals
$4750|GR - 337832|Published date: 12 December, 2024
Monkeypox Market Insight, Epidemiology, and Market Forecast 2024-2032
Pharmaceuticals
$4750|GR - 910952|Published date: 10 December, 2024
Morquio Syndrome Market Insight, Epidemiology, and Market Forecast 2024-2032
Pharmaceuticals
$4750|GR - 812321|Published date: 10 December, 2024
Mucinoses Market Insight, Epidemiology, and Market Forecast 2024-2032
Pharmaceuticals
$4750|GR - 834804|Published date: 10 December, 2024
Mucopolysaccharidosis Market Insight, Epidemiology, and Market Forecast 2024-2032
Pharmaceuticals
$4750|GR - 722442|Published date: 10 December, 2024
Multiple System Atrophy (MSA) Market Insight, Epidemiology, and Market Forecast 2024-2032
Pharmaceuticals
$4750|GR - 595504|Published date: 11 December, 2024
Muscle Spasticity Market Insight, Epidemiology, and Market Forecast 2024-2032
Pharmaceuticals
$4750|GR - 319914|Published date: 11 December, 2024
Muscle Invasive Bladder Cancer Market Insight, Epidemiology, and Market Forecast 2024-2032
Pharmaceuticals
$4750|GR - 677644|Published date: 11 December, 2024
Molybdenum Cofactor Deficiency Type A Market Insight, Epidemiology, and Market Forecast 2024-2032
Pharmaceuticals
$4750|GR - 260555|Published date: 10 December, 2024
Mitral Valve Disease Market Insight, Epidemiology, and Market Forecast 2024-2032
Pharmaceuticals
$4750|GR - 556233|Published date: 10 December, 2024
Mitochondrial Myopathies Market Insight, Epidemiology, and Market Forecast 2024-2032
Pharmaceuticals
$4750|GR - 772306|Published date: 10 December, 2024